GLP-1 price cuts announced for Wegovy, Ozempic

Novo Nordisk is cutting list prices for Wegovy, Ozempic and Rybelsus to $675 a month starting in 2027, aiming to improve affordability for insured patients.
Ready to start your GLP-1 journey?
Gila helps you build lasting habits, understand your body, and stay on track. Join the pilot for free.
Join the Pilot
